Suchergebnisse - "Pachón, Jerónimo"

PubPharm (272)

31

SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome

enthalten in: Scientific reports | 2021

von Salto-Alejandre, S. | Berastegui-Cabrera, J. | Camacho-Martínez, P. | +97

32

Serinol-Based Benzoic Acid Esters as New Scaffolds for the Development of Adenovirus Infection Inhibitors : Design, Synthesis, and In Vitro Biological Evaluation

enthalten in: ACS infectious diseases | 2021

von Mazzotta, S. | Berastegui-Cabrera, J. | Carullo, G. | +8

33

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19 : a multicentre cohort study

enthalten in: The Lancet. Infectious diseases | 2021

von Gutiérrez-Gutiérrez, B. | Del Toro, M. | Borobia, A. | +110

CommentIn: Lancet Infect Dis. 2021 Jun;21(6):744-745. - PMID 33636149

34

Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2021

von Miró-Canturri, A. | Ayerbe-Algaba, R. | Del Toro, R. | +3

35

Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli

enthalten in: Antibiotics (Basel, Switzerland) | 2021

von Miró-Canturri, A. | Ayerbe-Algaba, R. | Vila-Domínguez, A. | +3

36

SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load

enthalten in: The Journal of infection | 2021

von Berastegui-Cabrera, J. | Salto-Alejandre, S. | Valerio, M. | +21

CommentOn: J Infect. 2020 Sep;81(3):357-371. - PMID 32615199

37

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state : a multicentre cohort study (SAM-COVID-19)

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Rodríguez-Baño, J. | Pachón, J. | Carratalà, J. | +169

CommentIn: Clin Microbiol Infect. 2021 Feb;27(2):158-159. - PMID 33007475

38

Impact of Treating Asymptomatic Bacteriuria in Kidney Transplant Recipients : A Prospective Cohort Study

enthalten in: Antibiotics (Basel, Switzerland) | 2021

von Fontserè, S. | Infante-Domínguez, C. | Suárez-Benjumea, A. | +7

39

Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models

enthalten in: Antibiotics (Basel, Switzerland) | 2021

von Miró-Canturri, A. | Ayerbe-Algaba, R. | Jiménez-Mejías, M. | +2

40

A quick prediction tool for unfavourable outcome in COVID-19 inpatients : Development and internal validation

enthalten in: The Journal of infection | 2021

von Salto-Alejandre, S. | Roca-Oporto, C. | Martín-Gutiérrez, G. | +10

CommentOn: J Infect. 2020 Aug;81(2):282-288. - PMID 32479771